Fri, 06 Mar 2015 | BUSINESS SALE
A Canadian pension fund has acquired a UK-wide student accommodation provider in a deal worth £1.1 billion.
Liberty Living, which owns 40 student residences holding 16,700 rooms across 17 towns and cities in the UK, was sold to Canada Pension Plan Investment Board (CPPIB) for £1.1 billion by its previous owner Brandeaux Student Accommodation Fund.
The sale of the student accommodation business, established in 2000, was a result of a competitive auction process. It came after Brandeaux abandoned its original plan to float Liberty Living as a separate fund over the summer last year, due to "adverse public market conditions".
Managing director and head of real estate investments for Europe at CPPIB, Andrea Orlandi, explained: “As a long-term investor, this is an exciting investment for CPPIB and an ideal platform through which we can build further scale, capitalising on Liberty Living's position as one of the leading operators in the UK student accommodation sector.
“This sector is an attractive one for CPPIB and we expect to see continued demand for well-located and well-managed student residences such as those within the Liberty Living portfolio.”
Liberty Living's chief executive Charles Marshall added that the firm was looking forward to working on increasing their market share in the provision of high quality accommodation for students in the UK via a “long-term relationship” with CPPIB.
______________________________________________________________________
Related information:
Growing your business via M&A
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.